Chinese drugmaker preparing production lines for one billion doses of potential vaccines
The company is testing their final two vaccines.
With four Chinese vaccines in the final stages of development, a Chinese state-owned drugmaker is setting up vaccine production lines to prepare for distribution if one of the company's two vaccines is approved.
SinoPharm Group is testing its final two vaccines around the world on 50,000 people and is preparing to supply 1 billion doses, if approved. Thousands of Chinese healthcare workers and at-risk individuals have been given the experimental vaccines.
Vaccine developments are "in the last kilometer of a long march," SinoPharm Chairman Liu Jingzhen said. "The production capacity will reach 1 billion doses next year, ensuring sufficient safety."
The global race to develop a safe and effective vaccine is still ongoing. However, final candidates are nearing the end of development.
If China succeeds in being the first country to release a COVID-19 vaccine to the public, issues could arise in distributing the vaccine where there are strict certification rules — such as in Europe, Japan and the United States — while giving developing countries access.
News, Not Noise
- Johns Hopkins published then deleted an article questioning the U.S. coronavirus death rate
- State lawmakers seek to decertify Pennsylvania election results, citing 'substantial irregularities'
- 'Sooner the better.' Trump plans to take election case to Supreme Court, adviser says
- Kim Jong Un has locked down the capital & killed people in effort to keep the virus at bay
- Sidney Powell sues Georgia officials, alleging massive scheme to rig election for Joe Biden